Cigna (CI) — insider trading
Health Care
Cigna (CI) has 29 reported SEC Form 4 insider transactions in our data, including 14 open-market sales among the most recent 29 (latest 2026-06-12).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-12 | Kates Jamie G | Officer (Chief Accounting Officer) | Option exercise / conversion (derivative) | 899 | $0.00 | $0 | Form 4 |
| 2026-06-12 | Kates Jamie G | Officer (Chief Accounting Officer) | Open-market sale | 899 | $298.61 | $268.5K | Form 4 |
| 2026-06-12 | Kates Jamie G | Officer (Chief Accounting Officer) | Option exercise / conversion | 899 | $152.89 | $137.5K | Form 4 |
| 2026-06-01 | Koka Durga Prasad | Officer (EVP, Global CIO) | Shares withheld for taxes / exercise cost | 729 | $275.53 | $200.9K | Form 4 |
| 2026-05-29 | Kurian George | Director | Grant / award / vesting (derivative) | 108 | $277.40 | $30.0K | Form 4 |
| 2026-05-13 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion (derivative) | 7,971 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion (derivative) | 15,458 | $0.00 | $0 | Form 4 |
| 2026-05-13 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion | 7,971 | $197.35 | $1.57M | Form 4 |
| 2026-05-13 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion | 15,458 | $149.14 | $2.31M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion (derivative) | 85,519 | $0.00 | $0 | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion (derivative) | 103,595 | $0.00 | $0 | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 2,231 | $298.53 | $666.0K | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 15,319 | $298.24 | $4.57M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 2,017 | $296.84 | $598.7K | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 34,641 | $295.98 | $10.25M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 38,487 | $294.98 | $11.35M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 2,142 | $293.92 | $629.6K | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 7,861 | $292.88 | $2.30M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 12,315 | $291.95 | $3.60M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 13,732 | $291.01 | $4.00M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 41,099 | $290.00 | $11.92M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 13,839 | $288.85 | $4.00M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 14,292 | $287.96 | $4.12M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Open-market sale | 3,903 | $286.83 | $1.12M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion | 85,519 | $197.35 | $16.88M | Form 4 |
| 2026-05-12 | Cordani David | Director, Officer (Chairman & CEO) | Option exercise / conversion | 103,595 | $149.14 | $15.45M | Form 4 |
| 2026-04-22 | Hathi Neesha | Director | Grant / award / vesting | 782 | $0.00 | $0 | Form 4 |
| 2026-04-22 | McClellan Mark B. | Director | Grant / award / vesting | 782 | $0.00 | $0 | Form 4 |
| 2026-04-22 | FOSS ERIC J | Director | Grant / award / vesting | 782 | $0.00 | $0 | Form 4 |
Ask the chat about CI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Cigna (CI).
Last updated 2026-06-12 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.